CALM1 and neoplasm: In the present investigation, we found that CALM1 and EGFR were remarkably up-regulated in ESCC, compared with paired NAT and that over-expression of CALM1 and EGFR in ESCC was significantly associated with tumor progression and poor overall prognosis.